Somewhat Positive News Coverage Very Unlikely to Impact Delcath Systems (DCTH) Stock Price

Media stories about Delcath Systems (NASDAQ:DCTH) have been trending somewhat positive on Thursday, according to Alpha One. The research firm, a unit of Accern, identifies negative and positive news coverage by monitoring more than 20 million blog and news sources in real-time. Alpha One ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Delcath Systems earned a media sentiment score of 0.01 on Alpha One’s scale. Alpha One also gave media stories about the medical device company an impact score of 25 out of 100, indicating that recent news coverage is very unlikely to have an effect on the stock’s share price in the next several days.

Delcath Systems (NASDAQ:DCTH) traded down 4.02% during midday trading on Thursday, reaching $0.06. The company’s stock had a trading volume of 7,176,874 shares. Delcath Systems has a 1-year low of $0.05 and a 1-year high of $6.85. The company has a 50 day moving average of $0.11 and a 200-day moving average of $1.13. The company’s market capitalization is $245486.41.

TRADEMARK VIOLATION NOTICE: This piece was originally published by sleekmoney and is the sole property of of sleekmoney. If you are accessing this piece on another publication, it was illegally stolen and republished in violation of U.S. & international copyright & trademark legislation. The correct version of this piece can be viewed at

About Delcath Systems

Delcath Systems, Inc is a late-stage clinical development company with early commercial activity in Europe focused on cancers of the liver. The Company is a specialty pharmaceutical and medical device company developing its product, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS).

5 Day Chart for NASDAQ:DCTH

This story was originally published by sleekmoney ( and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at

Receive News & Ratings for Delcath Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delcath Systems Inc. and related companies with's FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *